These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3228084)

  • 1. Visual compatibility of hydroxyzine hydrochloride with various antineoplastic agents.
    Marquardt ED
    Am J Hosp Pharm; 1988 Oct; 45(10):2127. PubMed ID: 3228084
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride.
    Jimenez MD
    Am J Hosp Pharm; 1988 Jun; 45(6):1278. PubMed ID: 3414694
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of midazolam hydrochloride with common preoperative injectable medications.
    Forman JK; Souney PF
    Am J Hosp Pharm; 1987 Oct; 44(10):2298-9. PubMed ID: 3687973
    [No Abstract]   [Full Text] [Related]  

  • 4. Clarification of visual compatibility of hetastarch and ranitidine hydrochloride.
    Wohlford JG
    Am J Hosp Pharm; 1989 Sep; 46(9):1772. PubMed ID: 2478014
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of cimetidine hydrochloride with common preoperative injectable medications.
    Souney PF; Solomon MA; Stancher D
    Am J Hosp Pharm; 1984 Sep; 41(9):1840-1. PubMed ID: 6496520
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of dobutamine hydrochloride with other injectable drugs.
    Hasegawa GR; Eder JF
    Am J Hosp Pharm; 1984 May; 41(5):949-51. PubMed ID: 6731457
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection.
    Turowski RC; Durthaler JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2181-4. PubMed ID: 1781476
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injection.
    Marquardt ED
    Am J Hosp Pharm; 1990 Aug; 47(8):1802-3. PubMed ID: 2389789
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual compatibility of amiodarone hydrochloride injection with other injectable drugs.
    Hasegawa GR; Eder JF
    Am J Hosp Pharm; 1984 Jul; 41(7):1379-80. PubMed ID: 6465154
    [No Abstract]   [Full Text] [Related]  

  • 11. Compatibility of verapamil hydrochloride with other additives.
    Cutie MR
    Am J Hosp Pharm; 1981 Feb; 38(2):231. PubMed ID: 7211888
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of verapamil hydrochloride injection with commonly used additives.
    Cutie MR
    Am J Hosp Pharm; 1983 Jul; 40(7):1205-7. PubMed ID: 6881161
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of perphenazine with various antimicrobials during simulated Y-site injection.
    Gasca M; Fanikos J; Souney PF
    Am J Hosp Pharm; 1987 Mar; 44(3):574-5. PubMed ID: 3565416
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of lithium citrate syrup with 10 neuroleptic solutions.
    Theesen KA; Wilson JE; Newton DW; Ueda CT
    Am J Hosp Pharm; 1981 Nov; 38(11):1750-3. PubMed ID: 6118064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346.
    Van der Schoot SC; Nuijen B; Sood P; Thurmond KB; Stewart DR; Rice JR; Beijnen JH
    Pharmazie; 2006 Oct; 61(10):835-44. PubMed ID: 17069422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
    Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ
    Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of amphotericin B and flush solutions.
    Rice JK
    Am J Hosp Pharm; 1989 Dec; 46(12):2461. PubMed ID: 2603876
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of cibenzoline succinate with commonly used acute-care medications.
    Dahl JM; Roche VF; Hilleman DE
    Am J Hosp Pharm; 1987 May; 44(5):1123-5. PubMed ID: 3605123
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of hetastarch with injectable critical-care drugs.
    Wohlford JG; Fowler MD
    Am J Hosp Pharm; 1989 May; 46(5):995-6. PubMed ID: 2471410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.